What is Tuberculous Peritonitis?

Apr 14, 2022 Source: Cainiu Health
Dr. Jiang Weimin
Introduction
Tuberculous peritonitis is a chronic, diffuse inflammatory condition of the peritoneum caused by *Mycobacterium tuberculosis*. This disease can occur at any age but predominantly affects young and middle-aged adults. Its pathogenesis is primarily attributable to infection with *Mycobacterium tuberculosis*, with secondary pulmonary tuberculosis lesions and primary infections in other body sites serving as major sources of infection; the principal routes of spread are direct extension and intraperitoneal dissemination.

In daily life, tuberculous peritonitis is a relatively common chronic disease. Some individuals may overlook its early signs, leading to disease progression and adverse effects on overall health. So, what exactly is tuberculous peritonitis?

What Is Tuberculous Peritonitis?

Tuberculous peritonitis is a chronic, diffuse inflammatory condition of the peritoneum caused by Mycobacterium tuberculosis. It can occur at any age but predominantly affects adolescents and young adults. The primary pathogenic mechanism involves infection with M. tuberculosis, most commonly via direct spread from pre-existing pulmonary tuberculosis or hematogenous/lymphatic dissemination from extrapulmonary foci. Among women, genital tuberculosis—particularly tubal tuberculosis—is the most frequent underlying cause.

Tuberculous peritonitis presents with numerous associated symptoms. Once diagnosed, timely and appropriate treatment must be initiated to effectively control disease progression. Initial management typically involves pharmacotherapy, including anti-tuberculosis drugs and corticosteroids such as dexamethasone. Combination therapy with both anti-tuberculosis agents and corticosteroids may also be employed. If medical treatment proves ineffective, surgical intervention should be considered.

For patients with tuberculous peritonitis, strict adherence to prescribed medication regimens and regular monitoring of liver function are essential. Since anti-tuberculosis drugs carry a significant risk of hepatotoxicity, prompt identification of drug-induced liver injury is critical. During treatment, patients should ensure adequate sleep, maintain optimal energy and physical stamina, minimize physical exertion, and prioritize rest—thereby reducing metabolic demand and limiting absorption of toxins. We hope this information proves helpful to you.